For the quarter ending 2026-03-31, CELG-RI had -$635M decrease in cash & cash equivalents over the period. $757M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net earnings/(loss) | 2,678 | 1,085 | 2,195 | 1,313 |
| Depreciation and amortization, net | 594 | 977 | 1,011 | 1,011 |
| Deferred income taxes | 161 | -392 | -359 | -437 |
| Stock-based compensation | 146 | 133 | 139 | 137 |
| Impairment charges | 412 | 584 | 196 | 318 |
| Divestiture gains and royalties | 34 | 285 | 295 | 585 |
| Acquired iprd | 94 | 1,393 | 633 | 1,507 |
| Equity investment (gains)/losses, net | 134 | 190 | 190 | -22 |
| Contingent consideration fair value adjustments | - | 15 | 0 | 336 |
| Other adjustments | -21 | -308 | 74 | 12 |
| Receivables | -1,687 | -19 | -155 | 484 |
| Inventories | -14 | -71 | 90 | -4 |
| Accounts payable | 409 | -90 | 160 | 13 |
| Rebates and discounts | -3,495 | -2,398 | 1,703 | 881 |
| Income taxes payable | 187 | -324 | 887 | -621 |
| Other | 1,636 | -1,068 | -240 | -222 |
| Net cash provided by operating activities | 1,104 | 1,974 | 6,311 | 3,917 |
| Sale and maturities of marketable debt securities | 359 | 402 | 829 | 524 |
| Purchase of marketable debt securities | 781 | 78 | 665 | 621 |
| Proceeds from sales of equity investments | 391 | 16 | 49 | 0 |
| Capital expenditures | 347 | 370 | 320 | 361 |
| Divestiture and other proceeds | 312 | 279 | 279 | 513 |
| Acquisition and other payments, net of cash acquired | 65 | 1,707 | 1,874 | 285 |
| Net cash provided by/(used in) investing activities | -131 | -1,458 | -1,702 | -473 |
| Proceeds from issuance of short-term debt obligations | - | 0 | 0 | 0 |
| Repayments of short-term debt obligations | - | 0 | 0 | 0 |
| Other short-term financing obligations, net | 321 | -406 | 5 | 58 |
| Proceeds from issuance of long-term debt | - | 5,740 | 0 | 0 |
| Repayments of long-term debt | 500 | 10,068 | 229 | 643 |
| Repurchase of common stock | - | 0 | - | - |
| Dividends | 1,283 | 1,262 | 1,263 | 1,262 |
| Stock option proceeds and other, net | -98 | -33 | -3 | 11 |
| Net cash provided by/(used in) financing activities | -1,560 | -6,029 | -1,490 | -1,836 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -48 | 5 | -4 | 128 |
| Increase/(decrease) in cash, cash equivalents and restricted cash | -635 | -5,508 | 3,115 | 1,736 |
| Cash, cash equivalents and restricted cash at beginning of period | 10,218 | 15,726 | 12,611 | 10,875 |
| Cash, cash equivalents and restricted cash at end of period | 9,583 | 10,218 | 15,726 | 12,611 |
BRISTOL MYERS SQUIBB CO (CELG-RI)
BRISTOL MYERS SQUIBB CO (CELG-RI)